Search research articles
Contact Us
Filters
Showing results (91-100 of 141) with videos related to
Page
of 15
Sort By:
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry
Danny Jazmati, Barbara Hero, Theresa M Thole-Kliesch, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
Frontiers in Endocrinology
|
July 5, 2022
Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry
Michaela Kuhlen, Christina Pamporaki, Marina Kunstreich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project
Kieuhoa T Vo, Katherine K Matthay, John Neuhaus, et al.
Pediatric Blood & Cancer
|
March 4, 2014
Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010
Ines B Brecht, Claudia Bremensdorfer, Dominik T Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2018
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis
Carmen Dorneburg, Matthias Fischer, Thomas F E Barth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database
Daniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastoma
Idoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma
Johannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 141) with videos related to
Sort By:
Page
of 15
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry
Danny Jazmati, Barbara Hero, Theresa M Thole-Kliesch, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
Frontiers in Endocrinology
|
July 5, 2022
Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry
Michaela Kuhlen, Christina Pamporaki, Marina Kunstreich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project
Kieuhoa T Vo, Katherine K Matthay, John Neuhaus, et al.
Pediatric Blood & Cancer
|
March 4, 2014
Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010
Ines B Brecht, Claudia Bremensdorfer, Dominik T Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2018
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis
Carmen Dorneburg, Matthias Fischer, Thomas F E Barth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database
Daniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastoma
Idoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma
Johannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Page
of 15